Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

DSS Inc (NYSE American: DSS) Has Three IPO Spinoffs Planned For 2023 — Is It On Your Watchlist?

DSS, Inc.

By Ernest Dela Aglanu, Benzinga Since 2019 when DSS Inc. (NYSE American: DSS) embarked on a major transformation journey, the company has evolved into a multinational company operating businesses in nine divisions with over 40 subsidiaries. Headquartered in New York, the company has developed strong market positions in product packaging, biotechnology, direct marketing, commercial lending, securities, and investment management, alternative trading, digital transformation, secure living, and alternative energy. These nine divisions and 40 subsidiaries offer innovative, flexible, and real-world solutions that not only provide mutual benefits for businesses and their customers but also create sustainable value and opportunity for transformation and value creation A study of the company’s website and investor deck reveals growth in diverse market sectors which is being fueled by an “incubator” strategy of acquiring and developing assets to enhance shareholder value through calculated IPO spinoffs and a parametric share distribution strategy.(??) A Closer Look At DSS’s Financials This strategy appears to be having a positive impact on DSS’s financials. A due diligence dive into the company’s financials show that the company’s total Net Asset Value (NAV) as of September 30 last year was $182.6 million, or $1.31 NAV per Share. Third Quarter 2022 revenues ballooned astronomically by 172% Quarter to Quarter, total assets were valued at $264 million, up significantly from the $20 million in assets as of December 2019. As of March 10th, 2023, DSS’s Market Cap was $33.5 million ($0.24/share) meaning shares are trading at approximately an 80% discount from September 30th’s NAV per share of $1.31. The company’s revenue for Q3 2022 was more than $35.9 million, compared to $13.2 million in the same quarter of 2021, representing a 170% increase. Market Potential Could Be Massive DSS believes that the markets the company operates in have nearly unlimited potential, and the opportunities within multiple high-growth markets are endless, predominantly because entities within these sectors are contemporary, scalable, and offer recurring revenue streams. Product packaging is projected to surpass $1.3 trillion in market size by 2028. The biotechnology market is expected to be worth around $3.44 trillion by 2030. Direct Marketing is a global business generating approximately $180 billion and is projected to have its fifth year of double-digit growth in 2023 spurred by the new Gig Economy. Commercial Lending Growth was at a 14-Year High in 2022, and the market size valued at over $8 billion in 2020 is projected to reach almost $30 billion by 2030. Securities is a high-growth sector of $70 trillion, and REITs earnings increased 24.6% this past year. DSS certainly seems to be following a focused strategy to continue to create shareholder value. The company says it achieves this by focusing on key areas for growth, such as developing solid revenue growth, increasing profitability, and growing assets that drive stock price and market cap. Buying Assets - Securing businesses and infrastructure to generate revenue. Business Optimization - Identifying business needs, providing financial resources, and empowering and incentivizing the management teams of the subsidiary businesses to be successful. Positive EBITDA - Achieving positive earnings before interest, taxes, depreciation, and amortization (EBITDA) by creating economies of scale and revenue generation within those businesses. Public Offerings - Sharing success with existing and new shareholders through the periodic distribution of stock dividends as subsidiary spinoffs through an Initial Public Offering (IPO). Monetizing Growth In Key Sectors DSS is acquiring ownership positions or fully acquiring businesses in high-growth sectors to monetize its holdings. The company reports that by transitioning its revenue streams into exponential and emerging new business lines, operating the business to create growth opportunities and scalable and recurring revenue, and restructuring and developing assets to position them for growth and potential monetization, DSS will eventually be creating more shareholder value. With companies like Johnson & Johnson (NYSE: JNJ), General Electric Company (NYSE: GE), and 3M Co. (NYSE: MMM) recently making headlines due to spinoff opportunities for shareholders, one of the most unique aspects of DSS for investors could be its strategy of incubation and subsequent spinoff of companies under its wing, automatically providing investors with pure-play tickers just by owning shares of DSS. This article was originally published on Benzinga here. DSS is a multinational company operating businesses within nine divisions: Product Packaging, Biotechnology, Direct Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Digital Transformation, Secure Living, and Alternative Energy. DSS strategically acquires and develops assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy. Since 2019, under the guidance of new leadership, DSS has built the necessary foundation for achievable growth through the formation of a diversified portfolio of companies positioned to drive profitability in multiple high growth sectors. These companies offer innovative, flexible, and real-world solutions that not only provide mutual benefits for businesses and their customers, but also create sustainable value and opportunity for transformation. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice Contact Details Rick Lutz- TraDigital IR rick@tradigitalir.com Company Website https://www.dssworld.com/

March 13, 2023 09:25 AM Eastern Daylight Time

The LED Lighting Market’s Growth Is In Double Digit Rates And Order Books Are Growing – Applied UV (NASDAQ: AUVI) Sub Just Secured A Multi-Million Order From A Leading Luxury Developer

Applied UV, Inc.

By Ernest Dela Aglanu, Benzinga The global LED lighting market, thanks to players like Applied UV Inc. (NASDAQ: AUVI), is witnessing significant growth. The market size was valued at $68.9 billion in 2022 and is projected to reach $264.08 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.6% during the forecast period. One of the primary drivers of the market’s growth is the rising need for energy-efficient light sources. LED lights consume less energy and have a longer lifespan compared to traditional lighting sources such as incandescent bulbs, fluorescent tubes, and halogen lamps. As a result, LED lights are gaining popularity in both the residential and commercial sectors, leading to a surge in demand. Additionally, increasing environmental awareness and conscious efforts toward sustainability are also contributing to the growth of the LED lighting market. LED lights are free from toxic materials such as mercury that pose a threat to the environment and human health. Therefore, they are considered eco-friendly and have become the preferred choice for lighting solutions in many sectors. Governments worldwide are implementing favorable policies to encourage the adoption of LED lighting. In many countries, subsidies, incentives, and tax benefits are offered to consumers who opt for LED lights. These government initiatives have resulted in increased awareness and adoption of LED lights, further fueling the market’s growth. The increasing LED lighting adoption and growth of the market is good news for companies like Applied UV, Universal Display Corporation (NASDAQ: OLED), Energy Focus Inc. (NASDAQ: EFOI), and LSI Industries Inc. (NASDAQ: LYTS) that are developing products to meet growing demand. Within the industry, Applied UV seems to have carved a niche for itself as a provider of proprietary surface and air disinfection technology focused on Improving Indoor Air Quality (IAQ), specialty LED lighting, luxury mirrors and commercial furnishings – all of which serves clients globally in both the commercial and retail segments. The company’s products address needs in the healthcare, hospitality, food preservation, cannabis, education, and winery vertical markets. Applied UV has established strategic manufacturing partnerships and alliances, including Canon, Acuity, Johnson Controls, USHIO, Siemens, Grainger, and a global network of 64 dealers and distributors in 52 countries, offering a complete suite of products through its two wholly owned subsidiaries — SteriLumen Inc. and MunnWorks LLC. Multi-Million Dollar Order From Premier Developer Applied UV ’s growth and recent announcement of purchase orders totaling $4.55 million could interest investors and watchers of the LED lighting industry. The company recently revealed that its wholly owned subsidiary LED Supply Co. had secured a multi-million dollar purchase agreement from an unnamed premier co-living rental property developer The X Company (“X Co.”). The purchase orders consist of $2.67 million received and the balance of $1.88 million assured by the end of the second quarter. LED Supply Co. will provide back-lit mirrors, LED lighting and control systems for X Co.’s growing billion-dollar portfolio of properties. The orders will be fulfilled by LED Supply Co., in partnership with MunnWorks, who will manufacture the backlit mirrors in its newly acquired 100,000-square-foot Brooklyn, NY facility. “Having access to the MunnWorks’ high-end U.S.-made decorative backlit mirrors and case goods, at competitive prices, allows us to provide a better-quality product to our residents while staying within our allotted budget on a project,” Ben Brichta, Partner at X Co., said. The premier co-living rental property developer reports that it is active in six markets, with 5,000 beds in its current portfolio and over $1 billion in construction activity. The company says it is fully integrated — able to acquire, design, build and operate its real estate assets. X Co. buildings offer a high level of amenities and resident experiences in their unique combination of private rentals, co-living suites and co-working spaces. They also offer residents an unconventional club environment supporting the growing work-from-home segment with a state-of-the-art gym and fitness studios, social activities and dramatic shared spaces. The orders more than double X Co.’s previous orders with LED Supply Co. and expands them to include backlit mirrors supplied by Applied UV subsidiary MunnWorks, with subsequent orders planned for later this year. The joint order is the first in what the company expects to be many collaborative sales efforts forecasted as part of the merger of Applied UV, LED Supply Co. and PURO Lighting announced in January of this year. This article was originally published on Benzinga here. Applied UV is focused on the development and acquisition of technology that addresses infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s Airocide® air purification devices are research-backed, clinically proven, and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II Medical device, utilizes a proprietary photo-catalytic (PCO) bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors, and biological gasses into harmless water vapor and green carbon dioxide without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine-making facilities, commercial real estate, schools, dental offices, post-harvest, grocery, cannabis facilities, and homes. SteriLumen’s connected platform for Data-Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company’s Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices’ proximity. The Company’s patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen-intensive location. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Brett Maas- Hayden IR brett@haydenir.com Company Website https://www.applieduvinc.com/

March 13, 2023 09:15 AM Eastern Daylight Time

Redx Pharma sees potential for RXC004 as a combination therapy

Redx Pharma PLC

Redx Pharma PLC (AIM:REDX) chief medical officer Dr Jane Robertson speaks to Proactive's Thomas Warner after announcing that phase II data from the first group of patients being administered RXC004 for biliary tract cancer was not enough to support further development. Robertson highlights RXC004's potential for use as a combination therapy. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

March 13, 2023 08:32 AM Eastern Daylight Time

Video

Headline

Creo Medical Group PLC

Proactive research analyst Daniel Appiah speaks to Thomas Warner after publishing a new report on Creo Medical Group PLC (AIM:CREO) that follows a £33.7mln fundraise. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

March 13, 2023 08:28 AM Eastern Daylight Time

Video

MGC Pharmaceuticals "totally understands" CimetrA after MoA study

MGC Pharmaceuticals Ltd

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief medical officer Nadya Lisovoder speaks to Proactive's Thomas Warner after announcing the completion of an in-vitro pre-clinical mechanism of action (MoA) study for the European based bio-pharma company's CimetrA platform. Lisovoder says that the fact MGC "totally understands" CimetrA represents a "very important step" in the development process. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

March 13, 2023 08:26 AM Eastern Daylight Time

Video

Roberts & Ryan Investments Inc., America's first Service-Disabled Veteran-Owned broker-dealer, is pleased to welcome John Schoger as their newest Senior Advisor of Equity Capital Markets

Roberts & Ryan Investments, Inc.

Mr. Schoger joins Roberts & Ryan as their latest Senior Advisor, focused on equity capital markets and corporate access. He brings more than 20 years of capital markets expertise, including extensive experience in non-deal roadshow origination and execution. John began his career in finance as an institutional broker at Financial Asset Management before co-founding Voyager Institutional Services. He served as President of Voyager until it was acquired by Strategas Securities, LLC in 2013. While at Strategas, John served as Managing Director of Corporate Services. “Roberts & Ryan is proud to welcome John Schoger to its Advisory Board. John has over 20 years’ experience in the Equity business and will share his insights and market knowledge with the Roberts and Ryan team, furthering our efforts to build our brand,” commented Roberts and Ryan’s Head of Equities, Jim McDevitt. John serves as Vice President at AssetWatch, Inc. and is a member of the Board of Trustees for The ARC of Ohio, advocating for the rights of the developmentally disabled community. John earned a BA from Miami University, Oxford, Ohio and holds SIE and FINRA Series 7, 63, and 79 licenses. About Roberts and Ryan Investments, Inc. Roberts & Ryan Investments, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over one million dollars in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, primarily focusing on general wellness, mental health, and career transition. Contact Details Joe Pecoraro +1 917-658-8945 jpecoraro@roberts-ryan.com Company Website https://www.roberts-ryan.com

March 10, 2023 09:00 AM Eastern Standard Time

News Release

Ondine Biomedical shares Ottawa Hospital study on Steriwave nasal photodisinfection helping patients

Ondine Biomedical Inc

Ondine Biomedical Vice President for Clinical and Medical Affairs Jason Hickok joins Proactive's Natalie Stoberman to share the results of its 2022 quality improvement study for Steriwave nasal photodisinfection. Hickok says the study shows spine surgery patients treated with Ondine Biomedical’s Steriwave nasal photodisinfection on average had a 48% shorter length of hospital stay compared with those not treated. The study also shows there was a 33% reduction in the rate of return to the emergency department, as well as a 51% reduction in the rate of readmissions. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

March 09, 2023 11:36 AM Eastern Standard Time

Video

USMJ.com Partnership & New Products

North American Cannabis Holdings, Inc.

McapMediaWire - - North American Cannabis Holdings, Inc. (OTC: USMJ ) - USMJ.com has established a new partnership with Nature’s Perfect Hemp, out of Tennessee. Nature’s Perfect Hemp has a wide variety of products that range from CBD, Delta-8, Delta-9 & Delta-10 in various formats for customers to take their cannabinoids. Link to Nature’s Perfect Hemp products Some key facts about the partnership & products: All new products have been 3 party tested Vapes, Prerolls, Gummies come in a variety of flavors All Products are available for wholesale through USMJ looks to cultivate and grow partnerships with American Based companies for the ever-growing cannabis market. “I couldn’t be more excited about this partnership with David Cooper & Nature’s Perfect Hemp” says, Steven Rash, CEO, North American Cannabis Holdings. “It’s been a while since I’ve been excited from an opportunity standpoint, and we’ve been working hard to get this done. It’s ready and I hope our customers are ready.” David Cooper, CEO of Nature’s Perfect Hemp, started his company back in 2017. After dealing with pain from surgeries and rehabilitation he encountered Hemp. Just a couple drops a day relieved his pain and turned a complicated lifestyle into a normal lifestyle. Experimenting with his own personal formulation which allowed him to modify for his personal needs. These formulas became Nature’s Perfect Hemp. “Steve is a professional businessman, and exiting our meeting he was extremely about our future business together. We’re happy to have our products listed on USMJ.com ” says, David Cooper, CEO of Nature’s Perfect Hemp. “When we first chatted with USMJ, we knew there would be synergy and an opportunity for growth on both fronts.” Vendors looking to partner with USMJ.com may read about the process and apply here: https://usmj.com/pages/vendor-inquiries Background: USMJ.com is a line of business of North American Cannabis Holdings, Inc. USMJ.com is one of the largest and fastest growing marketplaces to shop for CBD, CBG, hemp and cannabis essentials. Additionally, UMSJ.com has multiple B2B programs and partnerships offering them access to the tools and products USMJ.com has to offer. Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. For More Information Contact Steven Rash North American Cannabis Holdings, Inc +1 888 694 8765 info@shopusmj.com David Cooper https://naturesperfecthemp.com info@naturesperfecthemp.com Contact Details North American Cannabis Holdings, Inc info@aciconglomerated.com Company Website https://usmj.com/

March 09, 2023 09:54 AM Eastern Standard Time

With Access To $20 Million In Financing, 1606 Corp Is Eyeing CBD Business Acquisitions As It Embarks On An Aggressive Growth Path

1606 Corp

By Ernest Dela Aglanu, Benzinga The global CBD market is on an upward trajectory, and there are no indications that the growth could be slowing down anytime soon. The market was valued at $5.18 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 16.8% from 2022 to 2030. The positive growth projections could be good news for industry watchers and players like 1606 Corp (OTC: CBDW), which plans to accumulate a diverse portfolio of cannabidiol (CBD) products and companies nationwide by consolidating the fragmented CBD industry via acquisitions. Due to the numerous benefits of CBD, including treating anxiety and seizures and reducing pain, there is growing demand for health and wellness purposes. This ever-increasing demand and rising acceptance and use of CBD products thanks to increasingly friendly government regulations could significantly benefit a player like 1606. $20 Million Financing For CBD Businesses Acquisition The company, in line with its growth plans, recently revealed on February 16 that it had secured $20 million in financing to acquire CBD businesses after entering into an Equity Financing Agreement. (8-K) “We’re moving fast. Now that we have our feet underneath us since receiving the ticker symbol CBDW and now we’re taking definitive steps toward adding shareholder value. This $20 million financing is going to allow us to buy profitable CBD companies, and we’ll be a great investment opportunity for investors around the world,” Greg Lambrecht, CEO and Chairman of 1606 Corp, said. In the next six to 18 months, the company aims to spend between $5 million to $20 million on acquiring established brands or a broad spectrum of companies that are into CCBD + hemp edibles and topicals that are about six years old. While 1606 didn’t divulge any specifics, they did say they are waiting on a signature to close an acquisition any day now. Compared to other players like Canopy Growth Corp. (NASDAQ: CGC), Jazz Pharmaceuticals PLC (NASDAQ: JAZZ), Nandan Denim Ltd. (NSE: NDL), and Aurora Cannabis Inc. (NASDAQ: ACB), the company’s difference and power with its acquisition war chest could be key, especially as it is able to act while valuations are attractive and push forward into the future of the industry. The Phoenix, Arizona-based company, which began trading on the OTC Market on January 17, is known to acquire and develop CBD brands, including Truz and CBD Singlez, with the aim of consolidating the fragmented CBD industry. Production Of New Inventory Of CBD Smokables To Supply 2500 Retail Outlets To actively engaged in a modern direct marketing campaign to continue the growth into individual retail stores, 1606 has hired a direct marketing industry veteran, Brent Duskin. He is expected to increase the company’s product footprints in more retail locations in the U.S. According to a statement by the company, Mr. Duskin has worked with Fortune 500 companies that complement CEO Greg Lambrecht’s experience and connections in retail distribution. Mr. Lambrecht has personally conducted business with over 30,000 retail stores in his career and is the foundation of the recent growth of 1606 CBD products. The company’s main product skew is CBD Singlz, a smokable CDB product. The displays hold three 25ct Singlz containing mango-flavored CBD rolls, Original Flavor, and Menthol. These products are enthusiastically being used by cigarette smokers to quit their addiction to nicotine. 1606 reports that it currently has enough inventory to fill orders for an additional 2500 retail locations. "The gap left as a result of the flavor ban on vaping and tobacco products has resulted in a lot of shelves being open, and we're aggressively taking advantage of that opportunity. The fact that the Federal Government will not be adding regulations to the CBD industry leads us to believe that the time is right now for the consolidation of the industry, and that’s why we’re excited to have a $20,000,000 opportunity in the next year to execute on that ideal," said Greg Lambrecht - CEO & Chairman of 1606 Corp (OTC | CBDW). For CBD business inquiries contact: acquisitions@cbd.inc. This article was originally published on Benzinga here. 1606 Corp acquires and develops CBD brands including Truz and CBD Singlez, (www.1606hemp.com). The company utilizes an acquisition model aimed at consolidating the fragmented CBD industry. 1606 Corp has a primary focus on Hemp and CBD products, brand development, and establishing distribution channels. 1606 Corp. was awarded the ticker symbol CBDW on January 1th, 2022 and began trading on the OTC Market on January 17th, 2023. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Greg Lambrecht greg@1606corp.com Company Website https://cbd.inc/

March 09, 2023 09:15 AM Eastern Standard Time

1 ... 130 131 132 133 134 ... 286